IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Foresite Capital Management V, LLC

Q3 2022 Holdings

Filed 2022-11-14 | 14 holdings | $34.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Aclaris Therapeutics, Inc.(ACRS)COM00461U105$19.8M1,258,24357.5%
Compass Therapeutics, Inc.(CMPX)COM20454B104$10.0M4,400,00029.2%
Invivyd, Inc.(IVVD)COM00534A102$4.5M1,431,82613.0%
Theseus Pharmaceuticals, Inc.COM88369M101$19.3K3,335,3460.1%
Hims & Hers Health, Inc.(HIMS)COM CL A433000106$18.5K3,319,7860.1%
Pardes Biosciences IncCOM69945Q105$17.4K9,400,5150.1%
Kinnate Biopharma Inc.COM49705R105$10.5K875,0010.0%
Somalogic, Inc.(SLGCUSD)COM CL A83444K105$10.2K3,516,4720.0%
Adicet Bio, Inc.(TORCEUR)COM007002108$9.7K680,0000.0%
Gemini Therapeutics, Inc.COM36870G105$4.0K2,435,1250.0%
Quantum-Si Incorporated(QSI)COM CL A74765K105$2.5K924,3790.0%
Enanta Pharmaceuticals, Inc.(ENTA)COM29251M106$2.2K42,2500.0%
23andMe Holding Co.COM CL A90138Q108$1.2K406,9130.0%
Pharvaris N.V.(PHVS)COMN69605108$26234,1420.0%